Insmed has launched a first-in-human Phase 1 trial testing its experimental ALS gene therapy INS1202 in people with the disease.

Hearing how a family found meaning in the midst of their loss reminds columnist Kristin Neva that she isn't alone in her grief with ALS.

For columnist Dagmar Munn, reducing uncertainty in one area of her life with ALS would mean keeping her ALS progression right where it is.

Experimental therapy RT1999 will soon be tested in the UK EXPERTS-ALS platform trial designed to rapidly screen potential ALS treatments.

Clinical & Scientific Conference, researchers and clinicians are talking about the central role of patients, families, and caregivers in driving change for people living with neuromuscular diseases.

Chris was diagnosed with ALS in 2024. Before that, he spent 40 years in the oil and gas industry, working and living in eight countries across five continents. He’s dedicated himself to helping others ...

Exposure to wildfire smoke can more than double the risk of respiratory failure or death for ALS patients, a study found.

ALS News Today joins the ALS Network’s ASK ME ALS webinar series as presenting sponsor, offering expert discussions on ALS ...

A mutation in the TDP-43 protein reduces the viability of motor neurons without triggering protein clumps, researchers found.